SFSG
NVS icon

Stearns Financial Services Group’s Novartis NVS Stock Holding History

Stearns Financial Services Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$423K Sell
4,860
-43
-0.9% -$3.73K 0.07% 103
2020
Q2 		$428K Buy
4,903
+43
+0.9% +$3.71K 0.07% 94
2020
Q1 		$401K Sell
4,860
-200
-4% -$17.8K 0.07% 99
2019
Q4 		$479K Hold
5,060
– – 0.08% 90
2019
Q3 		$440K Sell
5,060
-345
-6% -$31K 0.08% 90
2019
Q2 		$494K Sell
5,405
-928
-15% -$78.5K 0.09% 82
2019
Q1 		$546K Sell
6,333
-1,182
-16% -$94.9K 0.1% 81
2018
Q4 		$578K Sell
7,515
-359
-5% -$27.9K 0.12% 79
2018
Q3 		$608K Buy
7,874
+167
+2% +$12.3K 0.14% 76
2018
Q2 		$522K Sell
7,707
-167
-2% -$11.5K 0.13% 78
2018
Q1 		$570K Sell
7,874
-273
-3% -$20.8K 0.14% 74
2017
Q4 		$613K Sell
8,147
-560
-6% -$42.3K 0.15% 72
2017
Q3 		$670K Buy
8,707
+28
+0.3% +$2.12K 0.17% 69
2017
Q2 		$649K Sell
8,679
-104
-1% -$7.37K 0.16% 76
2017
Q1 		$585K Hold
8,783
– – 0.14% 82
2016
Q4 		$573K Sell
8,783
-439
-5% -$28.5K 0.15% 81
2016
Q3 		$652K Sell
9,222
-1,718
-16% -$125K 0.18% 77
2016
Q2 		$809K Hold
10,940
– – 0.23% 62
2016
Q1 		$710K Buy
10,940
+357
+3% +$24.3K 0.21% 65
2015
Q4 		$816K Sell
10,583
-117
-1% -$9.29K 0.24% 62
2015
Q3 		$881K Sell
10,700
-122
-1% -$10.9K 0.29% 55
2015
Q2 		$954K Hold
10,822
– – 0.29% 53
2015
Q1 		$956K Buy
10,822
+91
+0.8% +$8.07K 0.29% 54
2014
Q4 		$891K Sell
10,731
-60
-0.6% -$4.97K 0.29% 56
2014
Q3 		$910K Hold
10,791
– – 0.32% 53
2014
Q2 		$875K Sell
10,791
-243
-2% -$19.1K 0.32% 54
2014
Q1 		$841K Buy
11,034
+11
+0.1% +$802 0.32% 54
2013
Q4 		$794K Sell
11,023
-213
-2% -$14.8K 0.31% 57
2013
Q3 		$772K Sell
11,236
-114
-1% -$7.54K 0.34% 56
2013
Q2 		$719K Buy
+11,350
New +$738K 0.32% 58

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Stearns Financial Services Group's NVS Position: Q3 2020 in Review

Stearns Financial Services Group reduced its Novartis (NVS) stake by 0.88% in Q3 2020, selling an estimated $3.73K and leaving 4,860 shares worth $423K. The position accounts for 0.07% of the portfolio, ranked #103.

Stearns Financial Services Group first reported a position in NVS in Q2 2013 and has held it in 30 quarters since. The position peaked at $956K in Q1 2015. 1,118 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

  • Stearns Financial Services Group held 4,860 shares of Novartis worth $423K as of Q3 2020.
  • Stearns Financial Services Group sold 43 Novartis shares in Q3 2020, an estimated $3.73K.
  • Novartis made up 0.07% of Stearns Financial Services Group's portfolio in Q3 2020, its #103 holding.
  • Stearns Financial Services Group first reported a position in Novartis in Q2 2013 and has held it in 30 quarters since.
  • Stearns Financial Services Group's Novartis position peaked at $956K in Q1 2015.
  • 1,118 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on Stearns Financial Services Group's 13F filing for Q3 2020, filed 30 Oct 2020.